Login / Signup

Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites.

Takuya IwamotoMasaki MaedaIssei SaekiIsao HidakaKunihiko TajimaTsuyoshi IshikawaTaro TakamiIsao Sakaida
Published in: Journal of gastroenterology and hepatology (2018)
Dose reduction of diuretics may be effective for patients with reduced renal function for whom tolvaptan is ineffective or the effect is insufficient and may also improve outcomes of patients with hepatic cirrhosis by preventing a decline in renal function caused by an increased dose of diuretics.
Keyphrases
  • acute heart failure
  • polycystic kidney disease
  • heart failure
  • cell free
  • insulin resistance
  • glycemic control